Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron J Keizer

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
European Journal of Drug Metabolism and Pharmacokinetics|June 15, 2023
Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot StudyPaul A G de Klaver, Ron J Keizer, Rob Ter Heine, et al.
Therapeutic Drug Monitoring|January 23, 2026
Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic SyndromeAstrid Heida, Mendy Ter Avest, Ron J Keizer, et al.
Investigational New Drugs|May 8, 2010
Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studiesElena Soto, Ron J Keizer, Iñaki F Trocóniz, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Pharmaceutics|November 26, 2022
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Belen P Solans, Ying Lu, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Clinical Pharmacokinetics|April 17, 2021
Model-Based Estimation of Iohexol Plasma Clearance for Pragmatic Renal Function Determination in the Renal Transplantation SettingTom C Zwart, Aiko P J de Vries, Aline G J Engbers, et al.
Transplantation and Cellular Therapy|April 4, 2025
High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical TransplantationChristopher C Dvorak, Soohee Cho, Gabriel Salinas Cisneros, et al.
Breast Cancer Research : BCR|September 13, 2017
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H Bartelink, Brendan Prideaux, Gregor Krings, et al.
The Lancet. Haematology|October 18, 2016
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysisImke H Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
European Journal of Drug Metabolism and Pharmacokinetics|June 15, 2023
Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot StudyPaul A G de Klaver, Ron J Keizer, Rob Ter Heine, et al.
Therapeutic Drug Monitoring|January 23, 2026
Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic SyndromeAstrid Heida, Mendy Ter Avest, Ron J Keizer, et al.
Investigational New Drugs|May 8, 2010
Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studiesElena Soto, Ron J Keizer, Iñaki F Trocóniz, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Pharmaceutics|November 26, 2022
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Belen P Solans, Ying Lu, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Clinical Pharmacokinetics|April 17, 2021
Model-Based Estimation of Iohexol Plasma Clearance for Pragmatic Renal Function Determination in the Renal Transplantation SettingTom C Zwart, Aiko P J de Vries, Aline G J Engbers, et al.
Transplantation and Cellular Therapy|April 4, 2025
High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical TransplantationChristopher C Dvorak, Soohee Cho, Gabriel Salinas Cisneros, et al.
Breast Cancer Research : BCR|September 13, 2017
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H Bartelink, Brendan Prideaux, Gregor Krings, et al.
The Lancet. Haematology|October 18, 2016
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysisImke H Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, et al.
Pageof 6